These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34381359)

  • 1. Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors.
    Long JY; Guo HL; He X; Hu YH; Xia Y; Cheng R; Ding XS; Chen F; Xu J
    Front Pharmacol; 2021; 12():681842. PubMed ID: 34381359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
    He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
    Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
    BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms.
    Dai HR; Liu Y; Lu KY; He X; Guo HL; Hu YH; Xu J; Ding XS; Chen F; Cheng R; Jiao Z
    Pharmacol Res; 2022 Oct; 184():106416. PubMed ID: 36029933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine Therapy for Apnea of Prematurity: Role of the Circadian
    Guo HL; Long JY; Hu YH; Liu Y; He X; Li L; Xia Y; Ding XS; Chen F; Xu J; Cheng R
    Front Pharmacol; 2021; 12():724145. PubMed ID: 35145399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apnea of prematurity - characteristic and treatment].
    Goryniak A; Szczęśniak A; Śleboda D; Dołęgowska B
    Postepy Biochem; 2017; 63(2):151-154. PubMed ID: 28689383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
    Rostas SE; McPherson C
    Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
    Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
    Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post-marketing study to support paediatric labelling in China.
    Gao XB; Zheng Y; Yang F; Wang CH; Jiang ZH; Wu YE; Jacqz-Aigrain E; Ni SQ; Zhao W
    Br J Clin Pharmacol; 2021 Mar; 87(3):1155-1164. PubMed ID: 32687613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
    Vatlach S; Arand J; Engel C; Poets CF
    Neonatology; 2014; 105(2):108-11. PubMed ID: 24335098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns.
    Aranda JV; Beharry KD
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101183. PubMed ID: 33293242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?
    Natarajan G; Botica ML; Thomas R; Aranda JV
    Pediatrics; 2007 May; 119(5):936-40. PubMed ID: 17473094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Evaluation of Twice-Daily Dosing of Caffeine for Apnea of Prematurity.
    Rebentisch A; Kovey K; Denslow S
    J Pediatr Pharmacol Ther; 2021; 26(3):253-257. PubMed ID: 33833626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine in preterm infants: where are we in 2020?
    Moschino L; Zivanovic S; Hartley C; Trevisanuto D; Baraldi E; Roehr CC
    ERJ Open Res; 2020 Jan; 6(1):. PubMed ID: 32154294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates.
    Du L; Tong X; Chen C; Gao X; Gagnatelli A; Li J; Santoro D; Nicolardi S; Fabbri L;
    Front Pediatr; 2020; 8():76. PubMed ID: 32219085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.